Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23813863 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | thymidine | rs112723255 | unclassified | |
| a polymorphism in the tymp gene is associated with the outcome of hla-identical sibling allogeneic stem cell transplantation. | |||||||
| 23813863 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | thymidine | rs112723255 | only_studied | |
| in this work, we retrospectively evaluated the influence of a polymorphism in the tymp gene (rs112723255; g/a) upon the outcome of 448 patients subjected to allogeneic stem cell transplantation (allo-sct) from an human leukocyte antigen (hla)-identical sibling donor. | |||||||
| 24231474 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| in conclusion, hla-haploidentical stem cell transplantation may be feasible, with appropriate gvhd prophylaxis, for patients with pid who lack a fully matched donor. | |||||||
| 24327150 | HLA-DPA1 (HLA-DPA1) | stem cell transplantation | NA | NA | NA | unclassified | |
| the effect of hla-dpa1 and dpb1 matching status on clinical unrelated stem cell transplantation still needs to be elucidated. | |||||||
| 24467477 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| employing an allogeneic b cell bank, designed to cover the majority of hla types, allows fast gmp-compliant manufacturing for donor-specific ntreg for clinical application in organ and stem cell transplantation. | |||||||
| 24473781 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| matching for hla at the allele level is crucial for stem cell transplantation. | |||||||
| 24515816 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| as previously reported in one family cd3e deficiency causes scid.patientwe report on a patient with scid due to cd3e deficiency treated by hla-haploidentical stem cell transplantation (sct) (donor: mother) 15 years ago which resulted in development of normal t- and b-cell immunity. | |||||||
| 24596764 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| human leukocyte antigen (hla) matched hemopoietic stem cell transplantation is the treatment of choice. | |||||||
| 24605769 | HLA-DR3 (BROAD ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| these parameters allow further insight into the hematopoietic system and might lead to the development of novel stem cell transplantation models.materials and cd4-/- c57bl/6 mice, transgenic for human cd4 and hla-dr3, were irradiated in a single (3, 6, 8 and 12 gy) and fractionated (6 x 1 gy, 6 x 1.5 gy, 6 x 2 gy; twice daily) dose regimen. | |||||||
| 24750103 | HLA (HLA) | stem cell transplantation | NA | NA | NA | negative | |
| persistence of recipient human leucocyte antigen (hla) antibodies and production of donor hla antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation. | |||||||
Copyright 2024